Important notice

Class action against tobacco companies

If you need the Health Insurance Number of a tobacco victim, you must file a request for access to information for a deceased person. Find out more

Gouvernement du Québec
Régie de l’assurance maladie

Notice of alternative medication authorization, July 11, 2022

Legal publication
Updated on

 16 August 2022

This notice was published on August 16, 2022.

Tocilizumab (162 mg/0.9 ml (4 ml)), Tocilizumab (162 mg/0.9 ml (10 ml)) et Tocilizumab (162 mg/0.9 ml (20 ml)) remplace:

  • Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (syr)
  • Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (pen)
Download (.pdf)
 63.73 KB
Related topics